Compare Katakura Industries Co., Ltd. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROE of 5.85%
- The company has been able to generate a Return on Equity (avg) of 5.85% signifying low profitability per unit of shareholders funds
2
Weak Long Term Fundamental Strength with a 0.77% CAGR growth in Net Sales over the last 5 years
3
Poor long term growth as Net Sales has grown by an annual rate of 0.77% over the last 5 years
4
Positive results in Mar 26
5
With ROE of 6.21%, it has a attractive valuation with a 0.83 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
JPY 93,108 Million (Small Cap)
13.00
NA
0.02%
-0.22
6.21%
0.93
Revenue and Profits:
Net Sales:
11,157 Million
(Quarterly Results - Mar 2026)
Net Profit:
1,778 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.9%
0%
14.9%
6 Months
-0.99%
0%
-0.99%
1 Year
9.93%
0%
9.93%
2 Years
58.48%
0%
58.48%
3 Years
84.62%
0%
84.62%
4 Years
48.59%
0%
48.59%
5 Years
100.0%
0%
100.0%
Katakura Industries Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.77%
EBIT Growth (5y)
8.71%
EBIT to Interest (avg)
31.03
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.42
Tax Ratio
30.14%
Dividend Payout Ratio
33.20%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.70%
ROE (avg)
5.85%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
0.83
EV to EBIT
9.95
EV to EBITDA
6.76
EV to Capital Employed
0.79
EV to Sales
1.52
PEG Ratio
0.33
Dividend Yield
0.02%
ROCE (Latest)
7.90%
ROE (Latest)
6.21%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
11,157.00
10,507.00
6.19%
Operating Profit (PBDIT) excl Other Income
2,761.00
1,923.00
43.58%
Interest
31.00
32.00
-3.13%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,778.00
901.00
97.34%
Operating Profit Margin (Excl OI)
182.90%
100.00%
8.29%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 6.19% vs 11.90% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 97.34% vs -32.71% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
40,652.00
39,424.00
3.11%
Operating Profit (PBDIT) excl Other Income
8,757.00
6,947.00
26.05%
Interest
131.00
141.00
-7.09%
Exceptional Items
0.00
-902.00
100.00%
Consolidate Net Profit
5,815.00
3,744.00
55.32%
Operating Profit Margin (Excl OI)
144.10%
104.60%
3.95%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 3.11% vs -1.37% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 55.32% vs 15.88% in Dec 2024
About Katakura Industries Co., Ltd. 
Katakura Industries Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






